Cargando…
Usefulness of the Urine Methylation Test (Bladder EpiCheck(®)) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study
Urothelial bladder cancer is a heterogeneous disease and one of the most common cancers worldwide. Bladder cancer ranges from low-grade tumors that recur and require long-term invasive surveillance to high-grade tumors with high mortality. After the initial contemporary treatment in non-muscle invas...
Autores principales: | Peña, Karla B., Riu, Francesc, Hernandez, Anna, Guilarte, Carmen, Badia, Joan, Parada, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267544/ https://www.ncbi.nlm.nih.gov/pubmed/35807141 http://dx.doi.org/10.3390/jcm11133855 |
Ejemplares similares
-
The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence
por: Mancini, Mariangela, et al.
Publicado: (2020) -
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples
por: Fiorentino, Vincenzo, et al.
Publicado: (2023) -
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals
por: Gaga, Mina, et al.
Publicado: (2021) -
Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study
por: Peña, Karla Beatríz, et al.
Publicado: (2022) -
Study of Liquid-Based Cytology Using Next-Generation Sequencing as a Liquid Biopsy Application in Patients with Advanced Oncological Disease
por: Peña, Karla Beatríz, et al.
Publicado: (2023)